NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$8.32
+0.12 (+1.46%)
As of Nov 18, 8:05 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +410.3% upside
Low Target $26.30
Average Target $42.46
High Target $52.67
Current Price $8.32
Current
$8.32
Target
$42.46
$26.30 $42.46 avg $52.67
Scenario Analysis
Bear Case
$26.30
216.1%
Low target
Base Case
$42.46
+410.3%
Avg target
Bull Case
$52.67
+533.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$19.60
-57.6% from high
52-Week Low
$11.90
+-30.1% from low
Target vs 52W High
$42.46
+116.6% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 32 84% $293.85 -16.0%
ABT
Abbott Laboratories
Strong Buy 33 79% $123.47 +18.2%
ISRG
Intuitive Surgical Inc
Strong Buy 40 75% $219.77 -47.8%
MDT
Medtronic Plc
Buy 35 66% $192.46 +91.1%
MCK
Mckesson Corp
Strong Buy 22 82% $307.39 -71.7%
SYK
Stryker Corp
Strong Buy 35 77% $338.36 +6.4%
CVS
Cvs Health Corp
Strong Buy 32 88% $162.09 +99.3%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -75.1%